АНТИОКСИДАНТИ В ЛІКУВАННІ ХВОРИХ НА ХРОНІЧНУ ХВОРОБУ НИРОК ІІ-ІІІ СТАДІЇ

by O. M. Loboda, I. O. Dudar, O. M. Miuntal, V. V. Alekseeva, V. F. Krot
Published 2017-12-01

ANTIMICROBIAL RESISTANCE OF GRAM POSITIVE BACTERIA ISOLATED LNPATLENTS WLTHCHRONLCKLDNEYDLSEASSTAGE5D: PREVALENCE AND OUTCOMES

by І.М. Shifris, I.O. Dudar, V.F. Krot, V.T. Kruglikov, N.G. Aleksieva, T.N. Nechyporuk, Е. М. Grigorieva
Published 2015-04-01

ANALYSIS OF THE MORTALITY STRUCTURE IN HEMODIALYSIS PATIENTS

by I. M. Shifris, I. O. Dudar, I. I. Gonchar, V. F. Krot, E. K. Krasyuk, N. G. Aleksieva, M. Khil
Published 2017-12-01

CYTOKINE IMMUNITYINCKD PATIENTS TREATED WITH HD, HDF, PD

by V.E. Dryanska, I.O. Dudar, I. Shifris, Yu.I. Gonchar, O.M. Loboda, F.Z. Galsenluk, V.F. Krot
Published 2016-12-01

PENTOSAN POLYSULPHATE INFLUENCEON THE COURSE OF CHRONICKIDNEYDISEASE ST'. II - IV

by O. Dudari, M. Shifrisi, V.Ye. Driyanska, V.F. Krot, O.M. Loboda, K. Krasiuke, M.H. Krylova, Alexeeva N.G., T.P. Bryzhachenko
Published 2015-09-01

EFFICACY AND SAFETY OF IRON (III)–HYDROXIDE SUCROSE COMPLEX IN CORRECTION OF ANEMIA STAGE 5D CHRONIC KIDNEYDISEASE HEMODIALYSIS PATIENTS NOT TREATED BY ERYTHROPOIESIS–STIMULATING A...

by І. О. Dudar, I. I. Gonchar, І. М. Shifris, Е. К. Krasjuk, V. М. Savchuk, О. М. Loboda, F. О. Pruskiy, V. F. Krot, Т. М. Nechiporuk, N. G. Alekseeva
Published 2014-11-01